课题基金 / 基金详情

Efficacy and Safety of N-acetylcysteine (NAC) in patients with mild vascular cognitive impairment

Efficacy and Safety of N-acetylcysteine (NAC) in patients with mild vascular cognitive impairment
N-乙酰半胱氨酸(NAC)对轻度血管性认知障碍患者的疗效和安全性
批准号:
356077
负责人:
Lanctôt Krista L
金额:
$49.04万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-10-01 至 2021-10-01

项目摘要

项目成果

Lanctôt Krista L的其他基金

相似基金

相关文献

中文摘要
翻译
尽管有希望的线索,但到目前为止,阻止或逆转痴呆症的药物的临床试验都失败了。因此,痴呆症的治疗干预现在集中在那些有认知问题的人身上,这些人进展的风险很高,甚至
英文摘要
Despite promising leads, to date clinical trials of medications to halt or reverse dementia have failed. Consequently, treatment interventions for dementia are now focusing on those with cognitive problems who are at high risk of progressing, to interven
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exercise augmenting cognition tDCS (EXACT) trial: A pilot study of a combined exercise and transcranial direct current stimulation intervention for cognition
Methylphenidate-primed rTMS for apathy in neurocognitive disorders
Exercise as a primer for excitatory stimulation study (EXPRESS): A combined exercise and transcranial direct current stimulation intervention for cognition
Exercise as a primer for excitatory stimulation study (EXPRESS): A combined exercise and transcranial direct current stimulation intervention for cognition
海外基金